|
CN111902138A
|
|
Baclofen and acamprosate based treatment of alzheimer's disease in patients who have failed to respond to acetylcholinesterase inhibitor treatment
|
|
CA3061243A1
|
|
Idalopirdine-based combinatorial therapies of alzheimer's disease
|
|
US2018000813A1
|
|
Early treatment of CMT disease
|
|
WO2017134280A1
|
|
Novel combinatorial therapies of neurological disorders
|
|
EP3411025A1
|
|
Novel combinatorial therapies of neurological disorders
|
|
AU2016256808A1
|
|
New therapeutic approaches for treating CMT and related disorders
|
|
JP2017008078A
|
|
Baclofen and acamprosate based therapy of neurological disorders
|
|
WO2017001360A2
|
|
New diagnostic tools for charcot-marie-tooth disease
|
|
CN107667293A
|
|
Diagnostic tool for Ah Hereby sea Mo's disease
|
|
US2016193163A1
|
|
Therapeutic approaches for treating Parkinson's disease
|
|
US2020306211A1
|
|
Method for adapting doses of combination therapies
|
|
MX2016010967A
|
|
New compositions for treating mechanical neuronal injuries.
|
|
KR20160111013A
|
|
Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disorders
|
|
AU2014256372A1
|
|
New compositions for treating CMT and related disorders
|
|
EP3062782A1
|
|
Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
|
|
US2016206603A1
|
|
Composition comprising torasemide and baclofen for treating neurological disorders
|
|
US2014371229A1
|
|
Therapeutic approaches for treating parkinson's disease
|
|
US2014371277A1
|
|
Compositions for treating amyotrophic lateral sclerosis
|
|
US2014357648A1
|
|
Therapeutic approaches for treating Alzheimer's disease
|
|
EP3028049A2
|
|
Diagnostic tools for alzheimer's disease
|
